Mrs. Jennifer Ilconich, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 146 Valleycrest Dr, Cecil, PA 15321 Phone: 419-787-8678 |
News Archive
Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, today announced the launch of its ColoPrint microarray-based 18-gene expression signature for predicting the risk of distant recurrence for stage II colon cancer patients who have undergone surgery.
An analysis of previous studies finds an association between being a cancer survivor and being unemployed, compared to healthy individuals, especially for survivors of breast and gastrointestinal cancers, according to an article in the February 18 issue of JAMA, the Journal of the American Medical Association.
The class of immunotherapies known as checkpoint inhibitors have proven to be a highly effective and advantageous treatment option for many cancer patients, but they don't work well for everyone, and oncologists have no reliable way to determine in advance which patients are likely to respond to these drugs.
Human eyes naturally contain yellow pigment in the macula, a spot near the center of the retina responsible for high-resolution vision. Those with more yellow in their macula may have an advantage when it comes to filtering out atmospheric particles that obscure one's vision, commonly known as haze.
› Verified 4 days ago